Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! By
The Global, Regional, and National Burden of Oesophageal Cancer and Its Attributable Risk Factors in 195 Countries and Territories, 1990-2017: A Systematic Analysis for the Global Burden of Disease Study 2017 Publisher Pubmed



Nasrollahzadeh D14 ; Safiri S15, 16 ; Sepanlou SG6, 18 ; Fitzmaurice C20, 23 ; Ikuta KS22, 23 ; Bisignano C23 ; Islami F24 ; Roshandel G6, 25 ; Abolhassani H12, 26 ; Abugharbieh E27 ; Advani SM29, 30 ; Ahmed MB31, 32 ; Aichour MTE33 ; Akinyemiju T34, 35 Show All Authors
Authors
  1. Nasrollahzadeh D14
  2. Safiri S15, 16
  3. Sepanlou SG6, 18
  4. Fitzmaurice C20, 23
  5. Ikuta KS22, 23
  6. Bisignano C23
  7. Islami F24
  8. Roshandel G6, 25
  9. Abolhassani H12, 26
  10. Abugharbieh E27
  11. Advani SM29, 30
  12. Ahmed MB31, 32
  13. Aichour MTE33
  14. Akinyemiju T34, 35
  15. Akunna CJ36, 37
  16. Alahdab F38
  17. Alipour V40, 41
  18. Almasihashiani A47
  19. Almulhim AM48
  20. Anber NH49
  21. Arabloo J41
  22. Arabzozani M51
  23. Awedew AF52
  24. Badawi A53, 54
  25. Berfield KSS21, 55
  26. Berhe K57
  27. Bhattacharyya K59, 60
  28. Borzi AM61
  29. Bosetti C66
  30. Carreras G68
  31. Chu DT73
  32. Costa VM71
  33. Dagnew B75
  34. Gela JD76
  35. Demeke FM81
  36. Demoz GT83, 84
  37. Dianatinasab M17, 85
  38. Elbarazi I87
  39. Emamian MH86
  40. Etemadi A88
  41. Faris PS89, 90
  42. Filip I91, 93
  43. Fischer F94
  44. Gad MM95, 97
  45. Gallus S65
  46. Gebre AK58, 98
  47. Gebrehiwot TT31
  48. Gebremeskel GG56, 82
  49. Gebresillassie BM74, 99
  50. Ghasemikebria F25
  51. Ghashghaee A41, 45
  52. Ghith N100, 101
  53. Golechha M102
  54. Gorini G67
  55. Hafezinejad N13, 107
  56. Hajmirzaian A4, 109
  57. Harvey JD23
  58. Hashemian M6, 112
  59. Hassen HY113, 114
  60. Henok A114
  61. Hoang CL115
  62. Hosgood HD116
  63. Ilesanmi OS118, 119
  64. Irvani SSN110
  65. Jain C121
  66. James SL23
  67. Jee SH122, 123
  68. Jha RP124, 125
  69. Joukar F126, 127
  70. Kabir A42
  71. Kasaeian A9, 44
  72. Kassaw MW128, 129
  73. Kaur S130
  74. Khan EA137
  75. Khoja AT105, 138
  76. Kocarnik JM23, 139
  77. Komaki H140, 141
  78. Kumar V142
  79. Lasrado S144
  80. Li B145
  81. Manafi N43, 151
  82. Manda AL152, 153
  83. Mathur MR154, 155
  84. Mehta V156
  85. Mehta D157
  86. Mendoza W158, 159
  87. Mithra P160
  88. Mohammad KA90, 163
  89. Mohammadianhafshejani A164
  90. Mohammadpourhodki R165
  91. Mohammed JA166
  92. Mohebi F10, 11
  93. Mokdad AH20, 23
  94. Monasta L167
  95. Moosavi D46
  96. Moosazadeh M78
  97. Moradi G168, 169
  98. Moradpour F169
  99. Moradzadeh R47
  100. Naik G170
  101. Negoi I153, 172
  102. Nggada HA173, 174
  103. Nguyen HLT175
  104. Nikbakhsh R108, 176
  105. Nixon MR23
  106. Olagunju AT178, 179
  107. Olagunju TO177
  108. Padubidri JR161
  109. Patel S180
  110. Pathak M181
  111. Pham HQ175
  112. Rabiee N182
  113. Radfar A92, 184
  114. Rafiei A77, 79
  115. Ramezanzadeh K111
  116. Rathi P162
  117. Rawaf DL150, 187
  118. Rezaei N12, 188
  119. Roro EM84, 189
  120. Saad AM96
  121. Salimzadeh H6
  122. Samy AM190
  123. Sarveazad A39
  124. Sekerija M192, 193
  125. Sha F194
  126. Shamsizadeh M195
  127. Sheikhbahaei S8, 106
  128. Shirkoohi R2, 3
  129. Malleshappa SKS196
  130. Sinha DN198, 199
  131. Smarandache CG153, 172
  132. Soshnikov S200, 201
  133. Suleria HAR146
  134. Tadesse DB82, 202
  135. Tesfay BE203
  136. Thakur B204
  137. Traini E205
  138. Tran KB206
  139. Tran BX207
  140. Ullah I208
  141. Vacante M209
  142. Veisani Y210
  143. Vujcic IS211
  144. Weldesamuel GT82
  145. Xu R23
  146. Yazdifeyzabadi V212, 213
  147. Yuce D214
  148. Zhang ZJ217
  149. Malekzadeh R5, 18
  150. Naghavi M20, 23

Source: The Lancet Gastroenterology and Hepatology Published:2020


Abstract

Background Oesophageal cancer is a common and often fatal cancer that has two main histological subtypes: oesophageal squamous cell carcinoma and oesophageal adenocarcinoma. Updated statistics on the incidence and mortality of oesophageal cancer, and on the disability-adjusted life-years (DALYs) caused by the disease, can assist policy makers in allocating resources for prevention, treatment, and care of oesophageal cancer. We report the latest estimates of these statistics for 195 countries and territories between 1990 and 2017, by age, sex, and Socio-demographic Index (SDI), using data from the Global Burden of Diseases, Injuries, and Risk Factors Study 2017 (GBD). Methods We used data from vital registration systems, vital registration-samples, verbal autopsy records, and cancer registries, combined with relevant modelling, to estimate the mortality, incidence, and burden of oesophageal cancer from 1990 to 2017. Mortality-to-incidence ratios (MIRs) were estimated and fed into a Cause of Death Ensemble model (CODEm) including risk factors. MIRs were used for mortality and non-fatal modelling. Estimates of DALYs attributable to the main risk factors of oesophageal cancer available in GBD were also calculated. The proportion of oesophageal squamous cell carcinoma to all oesophageal cancers was extracted by use of publicly available data, and its variation was examined against SDI, the Healthcare Access and Quality (HAQ) Index, and available risk factors in GBD that are specific for oesophageal squamous cell carcinoma (eg, unimproved water source and indoor air pollution) and for oesophageal adenocarcinoma (gastro-oesophageal reflux disease). Findings There were 473 000 (95% uncertainty interval [95% UI] 459 000-485 000) new cases of oesophageal cancer and 436 000 (425 000-448 000) deaths due to oesophageal cancer in 2017. Age-standardised incidence was 5.9 (5.7-6.1) per 100 000 population and age-standardised mortality was 5.5 (5.3-5.6) per 100 000. Oesophageal cancer caused 9.78 million (9.53-10.03) DALYs, with an age-standardised rate of 120 (117-123) per 100 000 population. Between 1990 and 2017, age-standardised incidence decreased by 22.0% (18.6-25.2), mortality decreased by 29.0% (25.8-32.0), and DALYs decreased by 33.4% (30.4-36.1) globally. However, as a result of population growth and ageing, the total number of new cases increased by 52.3% (45.9-58.9), from 310 000 (300 000-322 000) to 473 000 (459 000-485 000); the number of deaths increased by 40.0% (34.1-46.3), from 311 000 (301 000-323 000) to 436 000 (425 000-448 000); and total DALYs increased by 27.4% (22.1-33.1), from 7.68 million (7.42-7.97) to 9.78 million (9.53-10.03). At the national level, China had the highest number of incident cases (235 000 [223 000-246 000]), deaths (213 000 [203 000-223 000]), and DALYs (4.46 million [4.25-4.69]) in 2017. The highest national-level agestandardised incidence rates in 2017 were observed in Malawi (23.0 [19.4-26.5] per 100 000 population) and Mongolia (18.5 [16.4-20.8] per 100 000). In 2017, age-standardised incidence was 2.7 times higher, mortality 2.9 times higher, and DALYs 3.0 times higher in males than in females. In 2017, a substantial proportion of oesophageal cancer DALYs were attributable to known risk factors: tobacco smoking (39.0% [35.5-42.2]), alcohol consumption (33.8% [27.3-39.9]), high BMI (19.5% [6.3-36.0]), a diet low in fruits (19.1% [4.2-34.6]), and use of chewing tobacco (7.5% [5.2-9.6]). Countries with a low SDI and HAQ Index and high levels of indoor air pollution had a higher proportion of oesophageal squamous cell carcinoma to all oesophageal cancer cases than did countries with a high SDI and HAQ Index and with low levels of indoor air pollution. Interpretation Despite reductions in age-standardised incidence and mortality rates, oesophageal cancer remains a major cause of cancer mortality and burden across the world. Oesophageal cancer is a highly fatal disease, requiring increased primary prevention efforts and, possibly, screening in some high-risk areas. Substantial variation exists in age-standardised incidence rates across regions and countries, for reasons that are unclear. © 2020 The Author(s).
Other Related Docs
11. Evaluating Long-Term Survival of Patients With Esophageal Cancer Using Parametric Non-Mixture Cure Rate Models, Journal of Zanjan University of Medical Sciences and Health Services (2019)